Newsroom

An AI-Generated Protein Helps T Cells Kill Cancer

Artificial intelligence-generated “minibinder” protein enhanced T cell binding to and killing of cancer cells. Cancer immunotherapies largely depend on T cells, which recognise cancer antigens via their receptors interacting with the major histocompatibility complex...

Read Article

Inducible CAR T Cells Target Solid Tumors Better

Chimeric antigen receptor (CAR) T cell therapy harnesses the patient’s immune system to target and destroy cancer cells, offering hope for blood cancers such as leukemia and lymphoma. However, its application in solid tumors has faced significant challenges. In an...

Read Article